FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology. Method for isolating and purifying immunoglobulins involves dissolving precipitate A in a sodium acetate buffer solution, viral solvent-detergent inactivation and chromatographic purification in a system of three serially connected columns, first of which is filled with particles of hydrophobic polymer sorbent, second – particles of anion-exchange polymer sorbent, third – particles of sulphocationite. First column is disconnected from the system and directed for regeneration, and the third one – for immunoglobulin G isolation. Second column is washed with water and eluted in two stages. At the first stage, admixtures of ballast protein and polymer compounds are eluted, at the second stage, immunoglobulins A and M are eluted with a sodium-acetate buffer solution containing sodium chloride. Fraction containing immunoglobulins A and M is subjected to ultrafiltration and additional purification on column with anion-exchange sorbent, performing stepwise elution.
EFFECT: invention enables to obtain highly purified immunoglobulins with high output in a simple technological scheme.
5 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CHROMATOGRAPHIC EXTRACTION OF IMMUNOGLOBULIN | 2010 |
|
RU2467783C2 |
METHOD OF IMMUNOGLOBULIN PURIFICATION (VERSIONS) | 2007 |
|
RU2332247C1 |
METHOD OF PREPARING IMMUNOGLOBULINS FOR INTRAVENOUS ADMINISTRATION AND OTHER IMMUNOGLOBULIN PREPARATIONS | 1999 |
|
RU2197500C2 |
METHOD FOR OBTAINING HOMOLOGOUS IMMUNOGLOBULIN AGAINST COVID-19 | 2022 |
|
RU2792819C1 |
METHOD FOR MAKING CERULOPLASMIN | 2008 |
|
RU2372097C1 |
METHOD OF VIRUS INACTIVATION FOR IMMUNOGLOBULIN PRODUCTION | 2007 |
|
RU2372940C2 |
PURIFICATION AND APPLICATION OF FACTOR, CONTRIBUTING TO WOUND HEALING | 2007 |
|
RU2520817C2 |
CERULOPLASMIN RECOVERY METHOD | 2007 |
|
RU2356560C1 |
METHOD OF PRODUCING COMPLEX OF IgG, IgM AND IgA IMMUNOGLOBULINS FOR INTRAVENOUS ADMINISTRATION | 2012 |
|
RU2492176C1 |
METHOD OF PRODUCING A VIRUS-FREE HUMAN IMMUNOGLOBULIN G SOLUTION FOR INTRAMUSCULAR ADMINISTRATION | 2018 |
|
RU2728724C2 |
Authors
Dates
2019-07-16—Published
2018-10-17—Filed